The QualityStocks Daily Wednesday, July 10th, 2019

Today's Top 3 Investment Newsletters

24/7 Trader (SPIN) +332.43%

StockMarketWatch (GTVI) +165.77%

QualityStocks (TWER) +100.00%

The QualityStocks Daily Stock List

Better Choice Company, Inc. (BTTR)

Street Insider, All Cap Research, TeleTrader, Stockwatch, TradingView, Simply Wall St, and Wallet Investor reported earlier on Better Choice Company, Inc. (BTTR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Better Choice Company, Inc. is an animal health and wellness CBD (cannabidiol) company listed on the OTCQB. It has acquired TruPet LLC and Bona Vida, Inc. Better Choice Company offers consumers a carefully curated collection of premium pet brands, hemp-derived CBD supplements, as well as other services that support pet wellness. The Company is based in New York, New York.

Better Choice’s TruPet is an online seller of ultra-premium, all-natural pet food, treats and supplements. TruPet has a special focus on freeze dried and dehydrated raw products. Bona Vida is a unique emerging CBD platform. Bona Vida’s focus is on developing a portfolio of brand and product verticals within the animal and human health and wellness space.

Better Choice’s corporate vision is to provide clean, holistic, and nutritional options for consumers who want to bring their own healthier lifestyle to their pets. The Company’s products promote wellness and support better and longer lives for pets.

Better Choice’s portfolio includes TruDog, an online seller of ultra-premium, freeze-dried raw pet food, treats and supplements, and Elvis Presley’s Hound Dog, an inventive CBD platform. In addition, the Company’s portfolio includes TruGold, a hemp-based product line, and Rawgo!, a premium dehydrated dog food. Furthermore, its portfolio includes Orapup, a dental health system for dogs, TruCat, a premium pet food and supplements brand for cats, as well as Pet Premium, a foremost pet insurance provider.

In late June, Better Choice announced a strategic partnership with Authentic Brands Group (ABG). ABG (New York City) is an international brand development, marketing and entertainment company and owner of Elvis Presley Enterprises LLC. This strategic partnership is to launch an all-new line of CBD pet products under the Elvis Presley Hound Dog brand. ABG manages, elevates, and builds the long-term value of over 50 consumer brands and properties through partnering with best-in-class manufacturers, wholesalers, and retailers.

Mr. Damian Dalla-Longa, Co-Chief Executive Officer of Better Choice Company, said, “We’re thrilled to partner with ABG on the launch of all-new Elvis Presley products. It’s important to align Better Choice with brands that are iconic and have global consumer appeal. As one of the most celebrated figures in music and pop culture and avid dog lover, The King of Rock ‘n’ Roll’s influence is unmatched.”

Better Choice Company, Inc. (BTTR), closed Wednesday's trading session at $5.84, up 8.5502%, on 1,850 volume with 11 trades. The average volume for the last 3 months is 10,442 and the stock's 52-week low/high is $1.32599997/$19.50.

chart

Valeritas Holdings, Inc. (VLRX)

StockTwits, Stocks Equity, StocksBeat, Alpha Stock News, Proactive Investors, Infront Analytics, Investors Observer, AI Stock Finder, Stockwatch, Stockhouse, MacroTrends, Nasdaq Trader, and Zacks reported previously on Valeritas Holdings, Inc. (VLRX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Valeritas Holdings, Inc. is a medical technology company and maker of the V-Go® Wearable Insulin Delivery device. A commercial-stage medical technology enterprise, its focus is on improving health and simplifying life for people with diabetes by developing and commercializing unique technologies. It sells V-Go® to third-party wholesalers and medical supply distributors. Valeritas Holdings has its corporate headquarters in Bridgewater, New Jersey. The Company operates its R&D functions in Marlborough, Massachusetts.

The V-Go® Wearable Insulin Delivery device is Valeritas’ flagship product. V-Go® is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes. It is worn like a patch and can eliminate the need for taking numerous daily shots.

V-Go administers a continuous pre-set basal rate of insulin over 24 hours. Moreover, it provides discreet on-demand bolus dosing at mealtimes. V-Go is the only basal-bolus insulin delivery device on the contemporary market specifically designed keepin

g in mind the needs of type 2 diabetes patients. V-Go is cleared for use in the U.S. and the E.U. It is commercially available in the U.S. Valeritas is developing two next generation single-use disposable V-Go devices - V-Go PreFill™ and V-Go SIM™. V-Go PreFill™ will allow Valeritas to sell V-Go along with the insulin in one commercial product. It will feature a prefilled insulin cartridge, which the patient can snap into the V-Go device eliminating the insulin-filling process. V-Go SIM™ will feature one-way communication to smart devices via RF/Bluetooth technology. V-Go Link™ will provide real-time tracking information of basal and bolus dosing utilization.

On June 24, 2019, Valeritas announced it surpassed a major milestone of selling greater than 20 million V-Go insulin delivery devices in the U.S. Subsequently, in June, Valeritas announced it filed a “Special 510(k): Device Modification” submission with the Food and Drug Administration (FDA), which includes using regular human insulin (RHI) in the device. If cleared, this would allow for a labeling change that would result in using an insulin that could be significantly less expensive for patients.

This week, Valeritas Holdings announced positive data from a retrospective study using the HealthCore Integrated Research Database (HIRD) comparing patients using V-Go to patients using multiple daily injection (MDI) therapy. The study demonstrates V-Go users experienced lower insulin dose requirements and lower diabetes-related medication cost. This is while lowering average blood sugar levels, as measured by A1c.

Valeritas Holdings, Inc. (VLRX), closed Wednesday's trading session at $3.75, up 27.551%, on 11,657,003 volume with 38,480 trades. The average volume for the last 3 months is 330,687 and the stock's 52-week low/high is $2.0999999/$34.00.

chart

Sono-Tek Corporation (SOTK)

Micro Small Cap, Silicon Investor, Simply Wall St, Stockwatch, Whale Wisdom, InvestorsHub, Information Vine, Zacks, CapitalCube, Street Insider, Marketbeat, OTC Markets, and Wallet Investor reported earlier on Sono-Tek Corporation (SOTK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sono-Tek Corporation designs and manufactures ultrasonic coating systems for applying on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and research and development/other markets worldwide. The Company is the foremost developer and manufacturer of ultrasonic coating systems. Its solutions are environmentally-friendly, efficient, and also highly reliable. Sono-Tek is based in Milton, New York.

Sono-Tek develops and manufactures ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for varied markets. These include specialized glass applications in construction and automotive. Ultrasonic coating is an inventive, environmentally-friendly, low velocity spray technology. It creates micron thickness, very uniform protective and functional thin films with no clogging and very little overspray.

The Company’s solutions enable considerable reductions in overspray, savings in raw material, water and energy usage. In addition, these solutions provide improved process repeatability, transfer efficiency, high uniformity, as well as decreased emissions.

Sono-Tek’s unique, patented coating systems provide total solutions to complex and diverse coating challenges in a host of global industries, from research and development (R&D) through high volume production. All of its ultrasonic coating systems integrate Sono-Tek ultrasonic nozzles, liquid delivery, and full system controls. Machines range from R&D tabletop systems, standalone fully enclosed programmable systems, and wide area continuous production inline systems.

Recently, Sono-Tek reported financial results for Q4 and fiscal year ended February 28, 2019. Strong demand in leading markets boosted Sales up 5.5 percent over fiscal 2018 to $11.6 million with Gross Margin of 45 percent. For Q4, Sales increased 1 percent over the prior-year period with a Gross Margin of 46 percent.

Dr. Christopher L. Coccio, Sono-Tek Chairman and Chief Executive Officer, said, "Our strategy to expand the addressable market for our unique ultrasonic coating technology continues to gain traction. We developed new, complex solutions for the Alternative Energy, Microelectronics and Medical markets during the year. These more complex solutions address high value applications for our customers and provide economically compelling alternatives to traditional coating technologies. We have focused our sales and marketing resources on these targeted opportunities and, combined with strong market conditions, drove sales up 5.5 percent to $11.6 million."

Sono-Tek Corporation (SOTK), closed Wednesday's trading session at $2.65, even for the day, on 7,148 volume with 11 trades. The average volume for the last 3 months is 2,872 and the stock's 52-week low/high is $1.80999994/$3.0999999.

chart

Amazing Energy Oil and Gas, Co. (AMAZ)

Energy Voice and Oil and Gas Investments Bulletin reported earlier on Amazing Energy Oil and Gas, Co. (AMAZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Amazing Energy Oil and Gas, Co. engages in the exploration, development, and production of oil and gas in the State of Texas and East New Mexico. It operates leaseholds in the Permian Basin where it holds the rights within a 70,000-acre leasehold in Pecos County, Texas and is surrounded by large independent oil and gas companies. Amazing Energy Oil and Gas also provides oilfield services to oil and gas well owners. OTCQX-listed, the independent oil and gas exploration and production Company has its corporate office in Plano, Texas.

In addition, Amazing holds 16,904 gross acres in Lea County, New Mexico that is held by production. The Company chiefly engages in the acquisition and exploitation of oil and natural gas properties with an emphasis on well-defined plays containing stacked pay zones such as the San Andres, Devonian, Pennsylvanian and Wolfcamp.

Regarding Pecos County, the Company’s position accounts for rights within 70,000 acres lease hold (roughly 100 sq. miles); 100 percent Working Interest (WI); 75 percent Net Revenue Interest (NRI). A total of 26 wells have been drilled on the property. These are either producing or in the process of being completed.

In West Sawyer, Lea County, New Mexico, Amazing Energy Oil and Gas development highlights include 16,904 gross acres; 10,051 net acres; 56 percent average WI and operatorship. Four horizontal wells have been drilled. Net Production = 32.4 BOPD.

Jilpetco is a wholly-owned subsidiary of Amazing Energy Oil and Gas. Jilpetco is an oilfield services company. It owns and operates drilling, completion, workers rigs and leases operational services equipment.

This past March, Amazing Energy Oil and Gas announced it successfully completed the WWJD #31H San Andres well. The Company is producing from the prolific San Andres formation. Amazing also provided an operational update on the first two of multiple planned rework procedures on its Permian Basin assets located in Pecos County, Texas and Lea County, New Mexico. Further to efforts on existing wells improving production and operational efficiencies, the Company drilled the WWJD #27 well to a total depth of 1600 feet and set pipe.

Mr. Willard McAndrew, III, Amazing's Chief Executive Officer, said "We are excited to announce successful completion across all of our recent field efforts and associated production results. We expect these wells will continue to increase daily production and move the needle on topline growth. Currently Amazing is producing approximately 140 bop/d which puts us close to cash flow neutrality at current prices."

Amazing Energy Oil and Gas, Co. (AMAZ), closed Wednesday's trading session at $0.15, even for the day, on 2,010 volume with 2 trades. The average volume for the last 3 months is 36,869 and the stock's 52-week low/high is $0.000099999/$0.404000014.

chart

BLOK Technologies, Inc. (BLPFF)

Awesome Penny Stocks, The Hot Penny Stocks, Growstox, TeleTrader, BlockchainStocks, Cantech Letter, Stockwatch, Investing News, Wallet Investor, Stockhouse, and GlobeNewswire reported beforehand on BLOK Technologies, Inc. (BLPFF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

BLOK Technologies, Inc. invests in and develops emerging companies in the blockchain technology sector. It provides capital, technology, and management services to produce blockchain-enabled business applications. The Company previously went by the name Aida Minerals Corp. It changed its name to BLOK Technologies, Inc. in January of 2018.

BLOK Technologies provides reliable and established opportunities for investors desiring to invest in blockchain technologies without the volatility. The Company enables investors to capitalize on opportunities in this developing sector without the exposure and risk of unproven investment approaches such as ICO’s (Initial Coin Offerings).

BLOK’s method is to identify early-stage technologies with the potential to disrupt and innovate within their chosen industry. The Company defines their opportunity, assesses their requirements, and provides them with the needed financing and expertise to ensure the success of their projects.

BLOK Technologies’ initial acquisition is Greenstream. Greenstream is the only consortium blockchain network for all companies, consumers, and government agencies in the Canadian Cannabis ecosystem to communicate and transfer assets and value. This is while complying with jurisdictional regulations.

Moreover, BLOK Technologies has a strategic investment in FogChain. This is a blockchain development, testing and deployment technology suite. BLOK Technologies has a $600K investment including equity exchange in FogChain.

This past February, BLOK Technologies announced it entered into a non-binding Letter of Intent (LOI) with Sierra Blockchain, Inc., a private U.S. corporation, to acquire 100 percent of the issued and outstanding shares. The LOI was signed on February 25th, 2019.

The LOI will be supplanted by a formal Definitive Stock Acquisition Agreement. BLOK Technologies will conduct due diligence. This includes an independent asset valuation and technical evaluation of the Software. Sierra is a developer of various software tools and apps utilizing proprietary blockchain methodologies. Sierra Blockchain has a license agreement with Intensity Mining Corp. to develop new products derived from Intensity Mining’s proprietary “low power” blockchain set of tools.

BLOK Technologies, Inc. (BLPFF), closed Wednesday's trading session at $0.01426, even for the day, on 5,750 volume. The average volume for the last 3 months is 22,028 and the stock's 52-week low/high is $0.004999999/$0.220599994.

chart

Rubicon Organics, Inc. (ROMJF)

Stock Alert, CannabisFN, Spotlight Growth, CannabisMarketCap, Investor News, Stockwatch, The Street, Stockhouse, Investorx, Green Market Report, TheCannalysts, Pot Stock News, and Investor Ideas reported earlier on Rubicon Organics, Inc. (ROMJF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Rubicon Organics, Inc. is a super-premium, organic cannabis producer and the Company has operations in Canada, Washington and California. It produces and sells cannabis in Canada. Additionally, it leases custom built facilities; and provides brand licensing to cannabis producers and processors in Washington and California. Rubicon has two world-renowned facilities and a portfolio of leading cannabis brands. OTCQX-listed, Rubicon Organics is based in Vancouver, British Columbia.

Rubicon’s team wrote the first organic regulatory standard for certified organic cannabis production. The Company’s team includes first-class cannabis, CPG (Consumer Packaged Goods), and finance experts. Rubicon has custom designed facilities in the best growing climates and distinguished brands in influential markets. In addition, Rubicon has multi-jurisdictional operations and sales and a European distribution partnership secured.

The Company is a Licensed Producer (LP) focused on building super-premium organic cannabis brands and its flagship Canadian facility is a 125,000 sq. ft. state-of-the-art hybrid greenhouse with industry leading LED lighting. It is situated on a 20-acre property in Delta, British Columbia.

Rubicon’s Washington facility is a newly built, 40,000 sq. ft. hybrid greenhouse and extraction facility. Rubicon has commenced production in both facilities with a combined Phase I capacity of 15,500 kg per year. This includes 4,500 kg leased to a Washington State licensed operator applying Rubicon’s proprietary organic cultivation methods. Also, the Company owns two award-winning U.S. cannabis brands. These are 1964 Supply Co.™ in California, and Doctor & Crook Co.™ in Washington.

Rubicon Organics recently announced the successful completion of the first commercial scale, organic harvest at its newly constructed 40,000 sq. ft. hybrid facility in Ferndale, Washington. The Washington Facility is a high-tech, venlo-style greenhouse.

Last month, Rubicon Organics announced that it has partnered with Cookies to exclusively license the Cookies brand in Washington State. Cookies is a top lifestyle and cannabis brand in California. By way of this partnership, Cookies cannabis strains will be grown at Rubicon's high-tech Washington greenhouse. The expectation is that the Cookies library of cannabis strains will be available for sale beginning in Q4 2019.

Also in June, Rubicon Organics announced it started commercial cultivation of super-premium organic cannabis using selected strains from its genetic library at its 125,000 square-foot, state-of-the-art hybrid greenhouse facility in Delta, British Columbia. It expects its first harvest in September 2019 for sale in the Canadian market in Q4 of 2019.

Rubicon Organics, Inc. (ROMJF), closed Wednesday's trading session at $2.3558, even for the day, on 80 volume with 2 trades. The average volume for the last 3 months is 2,290 and the stock's 52-week low/high is $1.29814994/$2.60999989.

chart

Trican Well Service Ltd. (TOLWF)

Micro Small Cap, Wallet Investor, Short Squeeze, Marketbeat, Analyst Ratings, Dividend Investor, Stockhouse, Morningstar, Market Screener, Capital Cube, Wallmine, and TradingView reported earlier on Trican Well Service Ltd. (TOLWF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trican Well Service Ltd. is an oilfield services company listed on the OTC Markets. Trican provides a broad variety of specialized products, equipment, and services used during the exploration and development of oil and gas reserves. The Company provides these and also technology for use in the drilling, completion, stimulation, and reworking of oil and gas wells chiefly in Canada. Trican Well Service has its corporate office in Calgary, Alberta.

The Company offers cementing solutions, cement plugs, lost circulation, gas migration prevention, cement design solutions, and laboratory solutions. It also offers surface, intermediate, production, liner, horizontal, and remedial/squeeze cementing services; as well as cement pumpers, bulk equipment, and cement auxiliary equipment.

Additionally, Trican Well Service provides reservoir solutions, including exploration, production analysis, and simulation and modeling services; and acidizing and production enhancement services. The Company also provides coiled tubing solutions including coiled tubing fracturing and acidizing, specially designed tools, well cleanouts, milling, high pressure jetting, e-coil (smart coil), in-house engineering, nitrogen gas lifting, and production enhancement, as well as equipment and tools.

Trican additionally offers industrial services, including chemical, mechanical, and bundle cleaning services, and also nitrogen services; pipeline services, such as commissioning, operating, and abandonment services; fracturing solutions and equipment; and well intervention tools.

Recently, Trican Well Service announced its Q1 results for 2019. Q1 2019 Revenue increased 46 percent versus Q4 of 2018 that is mainly attributable to increased activity levels. Increased activity is evidenced by an 88 percent improvement in Hydraulic Fracturing Utilization levels, from 44 percent in Q4 2018 to 83 percent in Q1 2019, and a sequential increase in Total Proppant Pumped of 62 percent.

Increased activity resulted in higher Gross Profit and adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) versus Q4 of 2018. Gross Profit and adjusted EBITDA for Q1 of 2019 was $8.2 million and $26.3 million, respectively. Adjusted EBITDA margins were positive in each of the fracturing, cementing, coiled tubing, and fluid management service lines, while the pipeline and industrial service line's adjusted EBITDA margin was negative during Q1 2019. Moreover, Net Loss for Q1 of 2019 was considerably reduced from that of Q4 of 2018.

Trican Well Service Ltd. (TOLWF), closed Wednesday's trading session at $0.815, up 4.4872%, on 8,500 volume with 8 trades. The average volume for the last 3 months is 3,950 and the stock's 52-week low/high is $0.659300029/$2.48749995.

chart

WEED, Inc. (BUDZ)

Penny Stock Tweets, Stock Invest, Finance Registrar, Advanced Equity Research, Green Market Report, Tip Ranks, The Street, FXStreet, Market Screener, Wallet Investor, InvestorsHub, Micro Cap Daily, Equities, Barchart, Micro Small Cap, YCharts, 4-Traders, Capital Cube, Street Register, TradingView, Investor Place, Insider Financial, Stockhouse and MarketWatch reported previously on WEED, Inc. (BUDZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

WEED, Inc. is a multi-national, multi-faceted, vertically-integrated world class cannabis organization. The Company’s commitment is to its worldwide goals and outreach across the complete spectrum of the cannabis industry to find treatments, therapies and medical cures using the Cannabaceae plant family. WEED has established WEED Israel (Cannabis) Ltd. as a wholly-owned subsidiary of WEED, Inc. (USA). OTCQB-listed, WEED has its head office in Tucson, Arizona.

WEED is structured as a holding company. It does business by way of its divisions, wholly-owned subsidiaries, and strategically placed collaborative partners to attain and promote its worldwide brand. WEED does not grow, harvest, produce, or sell any substance in violation of US Federal law under The Federal Controlled Substances Act. Furthermore, WEED meets all standards of international law for WEED, Inc. and its subsidiaries in foreign locales.

WEED has purchased a 4-acre property in La Veta, Colorado. This is where its wholly-owned subsidiary, Sangre AgroTech, is engaged in the previously announced 5-year, $15-plus million Cannabis Genomic Study. In association with the La Veta property, WEED received unanimous approval of the La Veta Town Council for a Commercial Redevelopment Permit to commence planned renovations and construction of the Bioscience Research Center for the operations of WEED’s subsidiary, Sangre AgroTech, to convert the existing buildings into laboratory facilities required for Sangre to conduct its research, along with additional security and ground buildout.

Sangre AT, LLC, d/b/a Sangre AgroTech, has started a five-year Cannabis Genomic Study to complete a genetic blueprint of the Cannabis plant genus, through creating a global genomic classification of the entire plant. Through targeting cannabis-derived molecules, which stimulate the endocannabinoid system, Sangre AgroTech’s research team plans to develop scientifically-valid and evidence-based cannabis strains for the production of disease-specific medicines. The aim of the research is to identify, collect, patent, and archive a collection of highly-active medicinal strains.

This past December WEED announced that its first of numerous cultivar DNA sequencing tests have been perfected and finalized. The Company's team of scientists is now going through the analytics evaluation. Reports are forthcoming.

Mr. Glenn E Martin, WEED’s Chief Executive Officer, said, “During this time our team designed, tested, and refined standard operating procedures for efficient DNA isolation and sequencing of Cannabis genomes. Extensive bioinformatics analysis of repeatable and variable regions has been performed on newly-generated DNA sequencing data of 26 landrace cultivars and several publicly available genomes.''

WEED, Inc. (BUDZ), closed Wednesday's trading session at $0.68, up 36.00%, on 563,001 volume with 406 trades. The average volume for the last 3 months is 73,691 and the stock's 52-week low/high is $0.50/$4.46999979.

chart

Concierge Technologies, Inc. (CNCG)

Light Speed Stocks, Epic Stock Picks, Nebula Stocks, MicrocapVoice, OTCPicks, PennyStocks24, Pumps and Dumps, ProTrader, EpicVIP Group, MomentumOTC, OnPointStockAlert, Penny Stock Prodigy, Penny Stock Titans, The Street, and TopPennyStockMovers reported previously on Concierge Technologies, Inc. (CNCG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Concierge Technologies, Inc. is a global conglomerate with operating businesses in financial services, food manufacturing, beauty products and security systems. The Company has facilities located in the U.S.A., New Zealand, and Canada. Concierge Technologies has its head office in Valley Center, California. The Company’s shares trade on the OTC Markets’ OTCQB.

Concierge Technologies operates through its wholly-owned subsidiaries - Original Sprout, Wainwright Holdings, Gourmet Foods, Ltd., and Brigadier Security Systems. In addition, USCF is a subsidiary of the Company.  USCF operates at the frontline of product innovation as an asset management firm offering exchange-traded products (ETPs), exchange-traded funds (ETFs), as well as mutual funds. 

Gourmet Foods is a well-established producer of popular New Zealand meat pies and bakery products under recognized supermarket brand names “Pat’s Pantry” and “Ponsonby Pies”. Gourmet Foods products are in convenience stores, major supermarkets, petroleum stations,  and restaurants. Gourmet Foods distributes greater than 30 products throughout New Zealand. 

Concierge Technologies’ Brigadier Security Systems of Saskatoon, Saskatchewan is an alarm installation and monitoring company. It is a long-standing security alarm business serving the Province of Saskatchewan since 1985. Brigadier has security solutions ranging from products designed to protect residential premises and property through to complex access control and camera monitoring equipment.  Brigadier Security Systems operates under the trade name Elite Security.

The Original Sprout subsidiary is a California-based manufacturer and international distributor of natural, 100 percent vegan, hair and skin care products. Master hair stylist Inga Tritt founded Original Sprout in 2003.

Recently, Concierge Technologies announced that its wholly-owned subsidiary, Original Sprout, launched a new, updated, website at www.originalsprout.com. Original Sprout is best known for its natural hair and body wash formulated for babies. However, this subsidiary’s product line has grown to include styling products for adults, such as protein hair mist, hair gel, reef safe sun block, shampoos and conditioners, and many more.

Mr. Michael Ambacher, Chief Operating Officer of Original Sprout, said, ''Original Sprout products are clinically tested by independent laboratories and are confirmed hypoallergenic, non-allergenic, cruelty-free and reef safe. Our new website highlights these attributes with fresh images and updated content. We are excited to get our message out and are looking forward to 2019 as a year we make significant progress in underserved market segments.''

Concierge Technologies, Inc. (CNCG), closed Wednesday's trading session at $1.00, up 52.8947%, on 434 volume with 3 trades. The average volume for the last 3 months is 679 and the stock's 52-week low/high is $0.550100028/$1.85000002.

chart

FieldPoint Petroleum Corp. (FPPP)

Stock Twits, OTC Markets, Equity Clock, Investing Note, InvestorsHub, Investors Hangout, Real Investment Advice, Market Screener, Wallet Investor, MarketWatch, The Street, and Street Insider reported earlier on FieldPoint Petroleum Corp. (FPPP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FieldPoint Petroleum Corp. engages in the acquisition, development, and operation of oil and natural gas properties in the U.S. The Company engages in oil and natural gas exploration, production, and acquisition, primarily in Louisiana, New Mexico, Oklahoma, Texas, and Wyoming. FieldPoint Petroleum has its corporate office in Austin, Texas. The Company lists on the OTC Markets’ OTCQB.

Currently, FieldPoint has varying ownership interests in 480 gross producing wells (96 net) in the above-mentioned States. The Company’s strategy centers on expanding its reserve base. This is while increasing production and cash flow through the acquisition of leasehold interests and producing oil and gas wells.

FieldPoint Petroleum has more recently chosen to concentrate on promising areas for oil & gas exploration. These areas include the Lusk Field in Lea County, New Mexico, and the Company’s Ranger Project in the Taylor Serbin Field near Giddings, Texas.

In projects such as these, FieldPoint Petroleum partners with companies that complement internal expertise in evaluating opportunities and in making investment decisions. Regarding producing oil & gas properties, FieldPoint operates 19 wells. Independent contractors operate the other wells per standard industry contracts.

In Wyoming, FieldPoint is active in Converse County and Campbell County. The Company is active in Lea County, Chaves County, and Eddy County in New Mexico. In Texas, FieldPoint is active in Andrews County, Midland County, and Lee & Bastrop Counties. In Louisiana, it is active in Caddo Parrish. In Oklahoma, the Company is active in Grady County and Pontotoc County.  

Concerning operated wells, FieldPoint’s portfolio includes mainly low-touch, “pumper and electricity-only” wells in the Devonian, Ellenberger, and Morrow areas of West Texas and New Mexico. Higher maintenance fields are closer to home. These include the Taylor Serbin field near Giddings, Texas. Most of FieldPoint’s production comes from its East Lusk and Serbin Fields.

Recently, FieldPoint Petroleum announced financial results for the third fiscal quarter ended September 30, 2018. Mr. Phillip Roberson, President and Chief Financial Officer, said, "Revenues were down year over year due primarily to the sale of our Apache Bromide production, which occurred in 2017. The Apache Bromide was a high operating cost asset that did not contribute significantly to the bottom line. We did not have a similar sale in 2018, although we are considering that possibility in the future. I am pleased to announce that we have been able to extend our forbearance agreement with Citibank until March 31, 2019, giving us some latitude to evaluate and consider merger, acquisition, and financing opportunities that have been difficult to pursue under a shorter forbearance period."

FieldPoint Petroleum Corp. (FPPP), closed Wednesday's trading session at $0.0796, up 58.8822%, on 1,061 volume with 1 trade. The average volume for the last 3 months is 4,843 and the stock's 52-week low/high is $0.05/$0.243.

chart

Metrospaces, Inc. (MSPC)

Stockwolf, Investors Hangout, Street Insider, Penny Stock Tweets, Stockhouse, Stock of the Week, InvestorsHub, OTC Markets, ClayTrader, Small Cap Network, Insider Financial, Barchart, WalletInvestor, MarketWatch, Emerging Growth, and Street Register reported earlier on Metrospaces, Inc. (MSPC),  and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Metrospaces, Inc. is a real estate investment and development Company. It acquires land, designs builds, and develops, then resells condominiums and Luxury High-End Hotels, chiefly in urban areas of Latin America. The Company is operated by a premier group of real estate and investment professionals and entrepreneurs located in New York, New York; Miami, Florida; and Buenos Aires, Argentina. Metrospaces’ current projects are in Buenos Aires, Argentina, and Caracas, Venezuela.

A start-up real estate private equity firm, Metrospaces is based in New York City. The Company’s refocusing of its business plan to U.S.-based projects is now complete. Metrospaces has strong relationships with Investment Bankers, Real Estate Entrepreneurs, Political Leaders and High Net-Worth Individuals around the world. The Company’s focus is on mid-sized deals.

Metrospaces looks to use its international relationships in financing and real estate developers to find co-investment and development opportunities in home building, residential and hotel. Furthermore, it will invest in operating companies that are real estate based. This includes hotel operators and senior facilities operators. Metrospaces will also invest in corporate reorganization.

The Company focuses on joint ventures (JV’s) with established players. Metrospaces’ majority shareholders have partnered with Investors on elite properties including The London BLVGARI 5 Star Hotel and are presently involved in negotiations for the development of a number of elite luxury properties in South America.

Metrospaces has executed a JV Agreement with Prohotels of Argentina. The agreement calls for the development of four new hotels in the coming three years.

Recently, Metrospaces announced a management decision to focus capital resources to its Cannabis-related real estate Company, CannPartners. At present, Metrospaces is looking at two properties, one in Connecticut and one in California. The Company is also keeping a strong focus on the New York market. It is in advanced talks for acquisition of those properties.

Mr. Oscar Brito, Metrospaces Executive President, said, “The continuing legalization of medical and recreational cannabis growing and distribution will continue in the US for the foreseeable future.  Many investors are focusing on the grow, distribution and ancillary industries such as paraphernalia etc.  However, even with the billions of dollars currently being invested in the cannabis industry, there are very few institutional investors solely focusing on the cannabis-related real estate side of the business.  In our opinion, this represents a once-in-a-generation opportunity to buy distressed and real estate located in out-of-favor locations across the U.S.”

Metrospaces, Inc. (MSPC), closed Wednesday's trading session at $0.0002, up 100.00%, on 340,628 volume with 6 trades. The average volume for the last 3 months is 18,255,837 and the stock's 52-week low/high is $0.000049999/$0.000699999.

chart

Towerstream Corp. (TWER)

MadPennyStocks, MarketClub Analysis, Money Morning, PennyOmega, OTCBB Journal, OTCMagic, Penny Picks, KingPennyStocks, BUYINS.NET, Damn Good Penny Picks, Penny Stock Prodigy, CoolPennyStocks, Epic Stock Picks, Hit and Run Candle Sticks, HotOTC, Investing Futures, MicroCapDaily, Investment Contrarians, Jason Bond, Broad Street, BullRally, PennyInvest, and ChartPoppers reported on Towerstream Corp. (TWER), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Towerstream Corp. is a leading Fixed-Wireless Fiber Alternative business.  The Company delivers high-speed Internet access to businesses. Together with its subsidiaries, it provides fixed wireless broadband services and delivers access over a wireless network transmitting over regulated and unregulated radio spectrum to commercial customers in the United States. Towerstream has its corporate office in Middletown, Rhode Island.

Towerstream announced earlier in 2018 that its Board of Directors started evaluation of strategic repositioning of the Company as it moves to take advantage of its existing important assets in major American markets. In association with the announcement, Towerstream launched a determined focus on indirect and wholesale channels and the retention of Bank Street Group LLC as its independent financial advisor to explore strategic alternatives with such broadband carriers.

Towerstream provides broadband services in twelve urban markets. These include New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area.  Towerstream has constructed 175 Major Points of Presence (POPs). The Company positions its POPs on the tops of buildings.

Towerstream is a last-mile facilities-based provider. It owns its entire network. The Company totally bypasses the local exchange carrier and cable providers. Its solution to businesses either complements or replaces existing Internet connections. Towerstream provides property managers, building owners, and their commercial tenants a redundant and reliable dense urban network. This network directly connects to the Company’s fiber backbone.  

Towerstream has its Single Tenant Internet Solution. This solution is for customers not in On-Net buildings. The Single Tenant Internet Solution provides primary and back-up dedicated internet access as a faster and less expensive alternative to fiber. On-Net refers to the extensive number of buildings in Towerstream’s 12 coverage markets now lit for On-Net Business Internet Service. The Company’s On-Net Service provides businesses within its continually growing portfolio of On-Net buildings with dedicated and symmetrical Internet connectivity.

Towerstream Fixed Wireless features fast installation, guaranteed 99.99 percent uptime backed by the Company’s industry leading SLA, and scalability. It also features faster than fiber, true redundancy, and symmetrical speeds.

Towerstream Corp. (TWER), closed Wednesday's trading session at $1.10, up 100.00%, on 2,082 volume with 7 trades. The average volume for the last 3 months is 153 and the stock's 52-week low/high is $0.50999999/$15.00.

chart

Force Protection Video Equipment Corp. (FPVD)

AimHighProfits, Promotion Stock Secrets,  and Insider Financial reported  earlier on Force Protection Video Equipment Corp. (FPVD), and today we highlight the Company, here at the QualityStocks Daily Newsletter. 

Force Protection Video Equipment Corp. (Force Protection)  sells high definition (HD) body camera systems and accessories for law enforcement. The Company offers its LE10 Law Enforcement Video Recorder product. Force Protection has its corporate headquarters in Cary, North Carolina

The Company previously went by the name Enhancer-Your-Reputation.Com, Inc. It changed its name to Force Protection Video Equipment Corp. in March of 2015. 

Force Protection has incorporated a wholly-owned subsidiary, CobraXtreme HD Corp., a North Carolina Corporation. This subsidiary’s purpose is to sell HD videos sports cameras and accessories that are alike to those sold by GoPro. Furthermore, it will sell video goggles and sunglass cameras.

CobraXtremeHD also carries a complete line of aftermarket accessories for extreme sports cameras such as GoPro® and Garmin®. The design of CobraXtremeHD cameras are for use in extreme sports. 

Force Protection has its LE50 HD Bodycam. The LE50 is a state-of-the-art designed body camera. It is strategically built around Ambarella chip sets (AMBA). Select important design features of the LE50 include industry leading record time (10 hours @1080,12 hours @720); 50 hours of standby time; 32GB of internal tamperproof storage; and white LED illumination.

Concerning the Company’s LE10 Law Enforcement Video Recorder product, it is a small bodyworn HD camera. It is half the size and half the price of most law enforcement cameras now on the market. The LE10 has manifold features. These include still picture ability 8MP, WIFI, 4x zoom,  and audio recording. The LE10 does not necessitate special software or costly storage contracts. 

In addition, Force Protection released the LE100 and LE101 1080 HD in car video recording dashcam systems. The LE100 and 101 are state-of-the-art designed in-car dash camera systems. They are strategically built around Ambarella A7 chip sets (AMBA).  

The Company also has its camera system for Law Enforcement and Security Agencies. The design of the C1, Citadel camera system is to fight and deter graffiti, illegal dumping, and other property crimes. The self-contained system is solar powered.  The C1 Citadel requires no external power. All of Force Protection’s cameras and recording devices have FCC, IC and CE certification.

Recently, Force Protection announced the release of the RECON 1000 on the body camera. The RECON 1000 incorporates into its design the Ambarella A7 chip to ensure its optimal performance for law enforcement officers. The RECON 1000 is a robust IP67 camera. It is small, lightweight and full of standard features that cameras twice its size and price do not include.

Force Protection announced in May that it received patent pending status from the U.S. Patent and Trademark Office (USPTO) for its proprietary design titled: Shield Harness for Mounting a Camera. The newly designed product will permit law enforcement departments to use existing body worn cameras with their riot shields to collect evidence during protests and disturbances and also to document inmate extraction in prisons. The design will enable the cameras to be mounted securely and have an unobstructed view point of individuals for later identification and for training.

Force Protection Video Equipment Corp. (FPVD), closed Wednesday's trading session at $0.0002, up 100.00%, on 3,100,000 volume with 2 trades. The average volume for the last 3 months is 485,444 and the stock's 52-week low/high is $0.000096/$0.000399999.

chart

MediPharm Labs Corp. (MEDIF)

New Cannabis Ventures, Equities, Stockwatch, Pot Stock News, Technical420, Midas Letter, MarketWatch, Stockhouse, Small Cap Power, Investing News, GuruFocus, Barchart, Seeking Alpha, Market Screener, Micro Small Cap, and Micro Cap Daily reported earlier on MediPharm Labs Corp. (MEDIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MediPharm Labs Corp. is an international leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation. The Company is the first in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation license. MediPharm Labs lists on the OTC Markets Group’s OTCQB. Established in 2015, the company is based in Barrie, Ontario.

MediPharm Labs is a leader in high-quality, industrial-scale cannabinoid-based derivatives. It is at the vanguard of cannabis extraction and purification. The Company delivers pure, safe and precisely dosable cannabis concentrates for private label advanced derivative products and employs state-of-the-art technology, as well as leading-edge proprietary methodologies.

MediPharm Labs is focusing on global opportunities in Australia and Asia Pacific targets, and European export. The Company has a strategic emphasis on the high growth and high margin segment. It has first mover advantage via technology, expertise, licensing and scale.

In Q4, 2018, MediPharm Labs became the first fully Licensed Producer to specialize exclusively in cannabis extraction. The Company also signed in Q4 a large private label cannabis oil sale agreement with Canopy Growth Corporation for the sale of up to 900 kg over 18 months. Furthermore, it expanded licensed extraction throughput capacity by 50 percent to 150,000 kg annually.

Recently, MediPharm announced Q4 and full year financial results for the year ended December 31, 2018. Q4 highlights include Revenue of $10.2 million, beginning November 12th after receipt of its sales license from Health Canada. Q4 highlights additionally include Gross Profit of $4.0 million and Gross Margin of 39 percent.

MediPharm Labs also recently announced the creation of its new Science Advisory Committee (the SAC). The SAC consists of a worldwide esteemed group of expert scientists, researchers, as well as medical professionals. The SAC will collaborate with the Company’s Management Team on advancements in the developing fields of cannabinoid extraction and cannabinoid-based derivative science.

Pat McCutcheon, Chief Executive Officer of MediPharm Labs, said, “We are extremely proud to bring together this distinguished group of experts. Each member brings a specialized expertise across the fields of extraction, chromatography, formulation, commercial development and pharmaceutical or physician approaches to cannabis science and medicine.”

MediPharm Labs Corp. (MEDIF), closed Wednesday's trading session at $3.52, off by 3.56%, on 270,381 volume with 568 trades. The average volume for the last 3 months is 331,774 and the stock's 52-week low/high is $0.9125/$5.65.

chart

The QualityStocks Company Corner

MustGrow Biologics Corp. (CSE: MGRO)

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity  

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers. MustGrow’s potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis. 

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated $9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.  

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.  Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis (TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

MustGrow Biologics Corp. (CSE: MGRO), closed Wednesday's trading session at $0.32, on 610,169 volume with 181 trades. The stock's 52-week low/high is $0.275000005/$0.699999988.

Recent News

chart

INmune Bio Inc. (NASDAQ: INMB)

The QualityStocks Daily Newsletter would like to spotlight INmune Bio Inc. (NASDAQ: INMB).

INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its co-founder and CEO, R.J. Tesi, M.D., presented at the Maxim Group’s conference on Alzheimer’s disease on June 26 in New York. To view the full press release, visit http://nnw.fm/GJ3sk.

INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.

INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.

INmune Bio's product pipeline targets three segments of concern:

  • Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
  • Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
  • Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.

INmune Bio Drug Candidates and Clinical Programs

INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.

In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").

Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.

INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.

Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.

XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.

The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.

Management

Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.

CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.

Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.

Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.

INmune Bio Inc. (OTC: INMB), closed Wednesday's trading session at $10.00, up 4.9318%, on 5,456 volume with 64 trades. The average volume for the last 3 months is 16,161 and the stock's 52-week low/high is $7.00/$11.50.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings (OTCQB: GRYN), a full-scope, science-driven, premium-cannabis cultivation and branding enterprise, recently entered a multiyear purchase order for the sale of hemp to U.S. Tobacco de Mexico (http://nnw.fm/mKA8N). To view the full article, visit: http://nnw.fm/wZm92.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed Wednesday's trading session at $1.39, up 2.963%, on 3,544 volume with 12 trades. The average volume for the last 3 months is 17,896 and the stock's 52-week low/high is $0.100100003/$1.80999994.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX:LXRP) (CNSX:LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, to provide Lexaria's patented DehydraTECHTM technology to Nic's Beverages Ltd for use in CBD-based beverages to be produced and sold throughout the United States.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.82365, up 6.2089%, on 249,248 volume with 102 trades. The average volume for the last 3 months is 84,390 and the stock's 52-week low/high is $0.75/$2.24.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC: VPRB) recently announced the availability of its ‘Guide to 2020 U.S. Presidential Candidates on Cannabis Issues’. The 2020 election may be the first for which the views of presidential candidates on marijuana issues have been compiled into a guide. VPR has sponsored this guide, which contains an extensive analysis of every candidate’s stance on cannabis issues (http://nnw.fm/4nATC).

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Wednesday's trading session at $0.0549, up 0.182482%, on 32,801 volume with 6 trades. The average volume for the last 3 months is 78,367 and the stock's 52-week low/high is $0.026/$0.119999997.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Leading telecommunications engineering and infrastructure services provider Spectrum Global Solutions (OTCQB: SGSI) today announced its decision to terminate the company’s definitive share purchase agreement with WaveTech Global, Inc. To view the full press release, visit: http://nnw.fm/Sq8Bn.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Wednesday's trading session at $0.05, even for the day, on 206,201 volume with 21 trades. The average volume for the last 3 months is 117,942 and the stock's 52-week low/high is $0.045000001/$2.5999999.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

ExpandsSugarmade Inc. (OTCQB: SGMD) plans to offer next-generation equipment and techniques to its customers that process and extract from industrial hemp to help meet what is anticipated to be a peak crop in 2019. To this end, SGMD was recently featured in a CannabisNewsWire analysis article discussing the hemp market’s rising demand for processing power (http://nnw.fm/89WwK). Also today, the company was featured in a report from NetworkNewsWire, explaining how SGMD is poised to benefit as the industrial hemp sector is forecasted to reach $13.03 billion by 2026 from $4.63 billion in 2018, increasing at a CAGR of 13.7% (http://nnw.fm/M1qBs). To view the full article, visit: http://nnw.fm/eVys8.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.021, off by 5.9772%, on 9,968,181 volume with 144 trades. The average volume for the last 3 months is 1,902,683 and the stock's 52-week low/high is $0.020999999/$0.197500005.

Recent News

chart

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a collaboration with Lift & Co. Corp ("Lift & Co.") (TSXV: LIFT) (OTCQB: LFCOF) to support the launch of Canada’s first branded cannabis educational program via Lift & Co.’s CannSell retail training program. Also today, the company was highlighted in a publication from Financialnewsmedia.com examining how, while some are ready to call it quits on cannabis, the Green Revolution is still just getting started.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Wednesday's trading session at $6.63, off by 4.1908%, on 1,489,936 volume with 5,409 trades. The average volume for the last 3 months is 963,794 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) was featured today in the 420 with CNW by CannabisNewsWire. The legalization of recreational cannabis has been linked to an 8 percent drop in the number of high school teens who confessed that they had used marijuana in the past 30 days. There was also a 9 percent drop in high schoolers who reported that they had used cannabis a minimum of 10 times in the past 30 days.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Wednesday's trading session at $4.32, off by 1.5945%, on 20,389 volume with 138 trades. The average volume for the last 3 months is 52,943 and the stock's 52-week low/high is $3.75/$10.6000003.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced that its portfolio company, YSS Corp. (TSXV: YSS) (WKN: A2PMAX), has received five cannabis retail licenses from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). To view the full press release, visit: http://nnw.fm/7eSEV. Also today, the company was highlighted in today's edition of Investorideas.com potcastsCM http://ibn.fm/ziUlb .

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (OTC: CNPOF), closed Wednesday's trading session at $2.5273, off by 3.9049%, on 129,751 volume with 371 trades. The average volume for the last 3 months is 109,894 and the stock's 52-week low/high is $1.75/$7.30155992.

Recent News

chart

Willow Biosciences Inc. (CSE: WLLW)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (CSE: WLLW).

Alberta, Canada-based Willow Biosciences (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. To view the full article, visit: http://nnw.fm/yrL50.

Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (CSE: WLLW), closed Wednesday's trading session at $0.85, off by 13.27%, on 155,614 volume with 94 trades. The average volume for the last 3 months is 49,128 and the stock's 52-week low/high is $0.850000023/$5.25.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

Warren Wang, CEO of ChineseInvestors.com Inc. (OTCQB: CIIX), predicted during a recent interview with Redchip Money Report that the company’s sales will reach $11‑12 million by 2020 (http://nnw.fm/Kbr1m). Wang further emphasized that though CBD had played an important role in the growth of the company, CIIX offers diverse services that aid in its growth, development and stability.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Wednesday's trading session at $0.41, off by 1.2048%, on 136,761 volume with 50 trades. The average volume for the last 3 months is 46,096 and the stock's 52-week low/high is $0.365000009/$1.25.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF), a global developer and provider of cellular communications systems, is responding to a critical need expressed by commercial fleet drivers and their public safety counterparts who need to concentrate on their jobs and not be distracted by antiquated communication systems. Specifically designed to ensure safer communications, Siyata’s Uniden UV350 is the world’s first in-vehicle 4G/LTE smartphone providing crystal clear audio quality via a single unit with built-in, carrier-grade Push-to-Talk, voice, text, video and data applications (http://nnw.fm/gvg8J).

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Wednesday's trading session at $0.3494, off by 0.569152%, on 75,000 volume with 7 trades. The average volume for the last 3 months is 57,278 and the stock's 52-week low/high is $0.288599997/$0.446249991.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

British Columbia-based QMC Quantum Minerals (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) recently received positive assay results from historical drill cores for two additional pegmatite dikes within its Irgon lithium mine property. To view the full article, visit: http://nnw.fm/e0zL4.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed Wednesday's trading session at $0.1274, off by 8.2133%, on 45,864 volume with 20 trades. The average volume for the last 3 months is 50,421 and the stock's 52-week low/high is $0.115500003/$0.319999992.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.